Why Concentration Math Matters in Peptide Research
Most research assay endpoints — in vitro cell culture, receptor binding, enzymatic assays — require compounds at precisely defined concentrations. Errors in concentration calculation propagate directly into dose-response curves, EC₅₀ determinations, and inter-experiment comparisons. A solution prepared at 10× intended concentration can saturate receptors and mask dose-response relationships; a 10× dilute solution may fall below detection thresholds entirely.
This guide covers the standard calculations for preparing peptide solutions from lyophilized starting material.
---
Key Terms and Units
Before calculating concentrations, it helps to define the units involved:
| Symbol | Unit | Definition |
| mg | milligram | 10⁻³ grams; the mass typically stated on the peptide vial label |
| µg | microgram | 10⁻⁶ grams (1 mg = 1,000 µg) |
| ng | nanogram | 10⁻⁹ grams (1 µg = 1,000 ng) |
| mL | milliliter | volume unit; 1 mL of water = 1 g at STP |
| µL | microliter | 10⁻³ mL (1 mL = 1,000 µL) |
| M | molar | moles per liter |
| mM | millimolar | 10⁻³ M (millimoles per liter) |
| µM | micromolar | 10⁻⁶ M (micromoles per liter) |
| nM | nanomolar | 10⁻⁹ M (nanomoles per liter) |
| MW | molecular weight | grams per mole (g/mol); also called molar mass |
---
Step 1: Know Your Starting Mass and Molecular Weight
Every calculation begins with two pieces of information from the vial label and COA:
1. Vial mass — the amount of lyophilized peptide in the vial (e.g., 5 mg)
2. Molecular weight — the molar mass of the compound (e.g., 711.9 g/mol for ipamorelin)
The MW for each compound appears on the Certificate of Analysis and is typically listed in g/mol. It can also be calculated from the sequence using online peptide calculators.
---
Step 2: Preparing a Stock Solution (mg/mL)
The simplest concentration unit for initial stock solution preparation is mg/mL (milligrams per milliliter), which requires no molecular weight calculation.
Formula:> Volume of solvent (mL) = Mass of peptide (mg) / Target concentration (mg/mL)
Example: Preparing a 1 mg/mL stock from a 5 mg vial of BPC-157 (MW 1419.5 g/mol):> Volume = 5 mg / 1 mg/mL = 5.0 mL of reconstitution solvent
Add 5.0 mL of bacteriostatic water to the 5 mg vial → 1 mg/mL stock solution.
---
Step 3: Converting mg/mL to Molar Concentration (µM, nM)
Many research assays specify concentrations in molar units (µM, nM). To convert from mg/mL to µM:
Formula:> Concentration (µM) = (mg/mL × 1,000,000) / MW (g/mol)
Or equivalently:
> Concentration (µM) = (mg/mL × 1000) / MW (g/mol) × 1000
Simplified form:> µM = (mg/mL / MW) × 10⁶
Example: 1 mg/mL BPC-157 (MW = 1419.5 g/mol):> µM = (1 / 1419.5) × 1,000,000 = 704.5 µM
So a 1 mg/mL BPC-157 stock is approximately 704.5 µM.
---
Step 4: Preparing a Target Molar Concentration Directly
If you want to prepare a solution at a specific molar concentration (e.g., 1 µM for a cell culture assay):
Formula:> Mass needed (mg) = Target concentration (µM) × Volume (mL) × MW (g/mol) / 1,000,000
Or rearranged for solvent volume when using the full vial:
> Volume (mL) = Mass (mg) × 1,000,000 / (Target µM × MW)
Example: Preparing 10 mL of 100 µM ipamorelin (MW = 711.9 g/mol) from a 5 mg vial:> Volume needed for 100 µM × 10 mL = 100 µM × 10 × 10⁻³ L × 711.9 g/mol = 711.9 µg = 0.7119 mg
So 0.7119 mg dissolved in 10.0 mL gives 100 µM. To use the full 5 mg vial:
> Volume = 5 mg × 1,000,000 / (100 µM × 711.9) = 5,000,000 / 71,190 = 70.2 mL
This would give a 100 µM stock from 5 mg of ipamorelin.
---
Step 5: Serial Dilutions
Serial dilutions are used to prepare a series of concentrations from a concentrated stock. They are especially useful for dose-response studies.
Formula (dilution factor):> C₁ × V₁ = C₂ × V₂
Where:
- C₁ = concentration of starting solution
- V₁ = volume of starting solution to transfer
- C₂ = target concentration of new solution
- V₂ = final volume of new solution
| Step | Stock in (µL) | Diluent (µL) | Final [C] |
| Stock | — | — | 1 mM (1,000 µM) |
| Step 1 | 50 µL from stock | 450 µL | 100 µM |
| Step 2 | 50 µL from Step 1 | 450 µL | 10 µM |
| Step 3 | 50 µL from Step 2 | 450 µL | 1 µM |
| Step 4 | 50 µL from Step 3 | 450 µL | 0.1 µM (100 nM) |
Each step takes 50 µL from the previous step and adds 450 µL of diluent — a 1:10 dilution.
---
Common Concentration Reference for Phase 1 Peptides Compounds
| Compound | MW (g/mol) | 1 mg/mL = (µM) | 1 mg in 1 mL solvent |
| BPC-157 | 1,419.5 | ~704 µM | 704 µM |
| TB-500 (LKKTET) | 679.8 | ~1,471 µM | 1.47 mM |
| Ipamorelin | 711.9 | ~1,405 µM | 1.40 mM |
| CJC-1295 No DAC | ~3,367 | ~297 µM | 297 µM |
| Tesamorelin | ~5,135 | ~195 µM | 195 µM |
| Sermorelin | 3,357.9 | ~298 µM | 298 µM |
| Tirzepatide | ~4,813 | ~208 µM | 208 µM |
| GHK-Cu | 401.9 | ~2,488 µM | 2.49 mM |
| SS-31 (Elamipretide) | 640.8 | ~1,561 µM | 1.56 mM |
| MOTS-c | 2,173.6 | ~460 µM | 460 µM |
| Epitalon | 390.4 | ~2,561 µM | 2.56 mM |
| DSIP | 848.9 | ~1,178 µM | 1.18 mM |
| Semax | 813.9 | ~1,229 µM | 1.23 mM |
| Selank | 751.9 | ~1,330 µM | 1.33 mM |
---
Practical Handling Tips
Weigh directly when possible: For high-precision work, weigh small mass aliquots directly on an analytical balance rather than relying on nominal vial content. Nominal mass can vary slightly from lot to lot within specification. Label all solutions immediately: Include compound name, lot number, concentration, solvent, and date prepared. Concentration errors are most often discovered days later when results don't make sense. Minimise pipetting error at low volumes: Below 10 µL, pipetting error becomes significant. For serial dilutions, work in volumes ≥50 µL per transfer when possible, or use a calibrated repeat-dispense pipette. Factor in solvent volume: When dissolving a powder, add slightly less solvent than calculated, mix to dissolve fully, then bring to final volume. This corrects for the small volume displacement contributed by the powder itself (usually negligible for typical research quantities but material at high concentrations).---
---
Common Questions
Q: What information is needed to convert a peptide from mg/mL to molar concentration?You need the molecular weight (MW) of the peptide, typically found on the Certificate of Analysis or compound specification. The formula is: molar concentration (µM) = (mass concentration in mg/mL ÷ MW in g/mol) × 1,000,000. For example, 1 mg/mL of BPC-157 (MW 1419.5 g/mol) equals approximately 704 µM. If the exact MW for your lot is not on the COA, use the theoretical MW from the sequence but note that salt form (TFA counterion) can add 5–15% to the actual mass.
Q: Why might the molecular weight on a COA differ slightly from published literature values?Published MW values are typically calculated from the free peptide sequence (the amino acid residues only). A supplied research peptide is usually in TFA salt form, where basic residues carry trifluoroacetate counterions — adding mass not counted in the free peptide MW. Additionally, some sources calculate MW including or excluding terminal modifications (NH2, amide, acetyl). The COA will typically specify the form used. For precise molar calculations, always use the lot-specific MW from the COA rather than a generic published value.
Q: What is the C1V1 = C2V2 equation and when is it used in research peptide work?C1V1 = C2V2 is the dilution equation: concentration times volume of the source solution equals concentration times volume of the target solution. It is used whenever you need to prepare a working concentration from a more concentrated stock. For example, preparing 500 µL of 10 µM working solution from a 1 mM stock: V1 = (10 µM × 500 µL) ÷ 1000 µM = 5 µL of stock, add 495 µL diluent. It also applies to serial dilutions — each dilution step is a C1V1 = C2V2 calculation. The equation assumes the solvent volume of the solute itself is negligible, which holds true for typical research peptide concentrations.
Q: How should concentration errors be avoided when reconstituting from a lyophilized vial?The most common source of error is adding solvent before calculating the target concentration. Best practice: (1) calculate the target volume of solvent before touching the vial; (2) add slightly less solvent than calculated initially, allow full dissolution, then bring to final volume; (3) label the vial immediately with concentration, solvent, date, and lot number; (4) use calibrated pipettes checked against a water reference before critical experiments. Reconstituted solutions should not be assumed to be stable indefinitely — check the stability guidelines for the specific compound.
Related Protocols
- How to Reconstitute Research Peptides
- Bacteriostatic Water Laboratory Guide
- Peptide Storage and Stability
- Lyophilization Explained
- Understanding Your Certificate of Analysis
- Peptide Half-Life Reference
All Phase 1 Peptides products are supplied exclusively for laboratory research and in vitro studies. They are not intended for human or animal consumption, clinical use, or therapeutic application.